Procyon Advisors’s Hologic HOLX Stock Holding History

Procyon Advisors’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,742	Closed	-$358K	–	619
2026 Q1	$358K	Sell	4,742 -14,231	-75%	-$1.07M	0.02%	417
2025 Q4	$1.41M	Buy	18,973 +2,944	+18%	+$215K	0.07%	225
2025 Q3	$1.08M	Buy	16,029 +5,501	+52%	+$365K	0.06%	228
2025 Q2	$686K	Sell	10,528 -680	-6%	-$40.8K	0.06%	238
2025 Q1	$692K	Buy	+11,208	New	+$743K	0.04%	319
2020 Q3	–	Sell	-9	Closed	-$1K	–	555
2020 Q2	$1K	Hold	9	–	–	﹤0.01%	988
2020 Q1	$0	Hold	9	–	–	﹤0.01%	1062
2019 Q4	$0	Buy	+9	New	+$448	﹤0.01%	1024

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Procyon Advisors's HOLX Position: Q2 2026 in Review

Procyon Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 4,742 shares — an estimated $358K sold.

Procyon Advisors first reported a position in HOLX in Q4 2019 and held it in 8 quarters. The position peaked at $1.41M in Q4 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Procyon Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Procyon Advisors sold 4,742 Hologic shares in Q2 2026, an estimated $358K.
Procyon Advisors first reported a position in Hologic in Q4 2019 and held it in 8 quarters.
Procyon Advisors's Hologic position peaked at $1.41M in Q4 2025.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.